130 related articles for article (PubMed ID: 37788733)
1. Investigating potential of cholic acid, syringic acid, and mangiferin as cancer therapeutics through sphingosine kinase 1 inhibition.
Shakeel I; Khan S; Roy S; Sherwani F; Ahmad SF; Sohal SS; Afzal M; Hassan MI
Int J Biol Macromol; 2023 Dec; 253(Pt 5):127036. PubMed ID: 37788733
[TBL] [Abstract][Full Text] [Related]
2. Investigation of sphingosine kinase 1 inhibitory potential of cinchonine and colcemid targeting anticancer therapy.
Roy S; Khan S; Jairajpuri DS; Hussain A; Alajmi MF; Islam A; Luqman S; Parvez S; Hassan MI
J Biomol Struct Dyn; 2022 Sep; 40(14):6350-6362. PubMed ID: 33565370
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.
Gupta P; Mohammad T; Khan P; Alajmi MF; Hussain A; Rehman MT; Hassan MI
Biomed Pharmacother; 2019 Oct; 118():109245. PubMed ID: 31352240
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of binding and inhibition mechanism of dietary phytochemicals with sphingosine kinase 1: Towards targeted anticancer therapy.
Gupta P; Mohammad T; Dahiya R; Roy S; Noman OMA; Alajmi MF; Hussain A; Hassan MI
Sci Rep; 2019 Dec; 9(1):18727. PubMed ID: 31822735
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of novel benzimidazole derivatives as sphingosine kinase 1 inhibitor.
Khairat SHM; Omar MA; Ragab FAF; Roy S; Turab Naqvi AA; Abdelsamie AS; Hirsch AKH; Galal SA; Hassan MI; El Diwani HI
Arch Pharm (Weinheim); 2021 Sep; 354(9):e2100080. PubMed ID: 34128259
[TBL] [Abstract][Full Text] [Related]
6. A 50-Hz magnetic-field exposure promotes human amniotic cells proliferation via SphK-S1P-S1PR cascade mediated ERK signaling pathway.
Chen L; Xia Y; Lu J; Xie Q; Ye A; Sun W
Ecotoxicol Environ Saf; 2020 May; 194():110407. PubMed ID: 32146198
[TBL] [Abstract][Full Text] [Related]
7. Discovering Gummadiol and Isoarboreol as potential inhibitors of sphingosine kinase 1: virtual screening and MD simulation studies.
Elasbali AM; Al-Soud WA; Alhassan HH; Mousa Elayyan AE; Kamal M; Alanazi H; Alharbi B; Alharethi SH; Mohamed BM
J Biomol Struct Dyn; 2023; 41(22):12789-12797. PubMed ID: 36644886
[TBL] [Abstract][Full Text] [Related]
8. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target.
Wang X; Sun Y; Peng X; Naqvi SMAS; Yang Y; Zhang J; Chen M; Chen Y; Chen H; Yan H; Wei G; Hong P; Lu Y
Cancer Control; 2020; 27(1):1073274820976664. PubMed ID: 33317322
[TBL] [Abstract][Full Text] [Related]
9. Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.
Li H; Sibley CD; Kharel Y; Huang T; Brown AM; Wonilowicz LG; Bevan DR; Lynch KR; Santos WL
Bioorg Med Chem; 2021 Jan; 30():115941. PubMed ID: 33385956
[TBL] [Abstract][Full Text] [Related]
10. Sphingosine kinase 1 in viral infections.
Carr JM; Mahalingam S; Bonder CS; Pitson SM
Rev Med Virol; 2013 Mar; 23(2):73-84. PubMed ID: 22639116
[TBL] [Abstract][Full Text] [Related]
11. Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.
Congdon M; Fritzemeier RG; Kharel Y; Brown AM; Serbulea V; Bevan DR; Lynch KR; Santos WL
Eur J Med Chem; 2021 Feb; 212():113121. PubMed ID: 33445156
[TBL] [Abstract][Full Text] [Related]
12. The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.
Zheng X; Li W; Ren L; Liu J; Pang X; Chen X; Kang D; Wang J; Du G
Pharmacol Ther; 2019 Mar; 195():85-99. PubMed ID: 30347210
[TBL] [Abstract][Full Text] [Related]
13. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
Lynch KR; Thorpe SB; Santos WL
Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
[TBL] [Abstract][Full Text] [Related]
14. AP-1 regulates sphingosine kinase 1 expression in a positive feedback manner in glomerular mesangial cells exposed to high glucose.
Huang K; Huang J; Chen C; Hao J; Wang S; Huang J; Liu P; Huang H
Cell Signal; 2014 Mar; 26(3):629-38. PubMed ID: 24342046
[TBL] [Abstract][Full Text] [Related]
15. Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy.
Jairajpuri DS; Mohammad T; Adhikari K; Gupta P; Hasan GM; Alajmi MF; Rehman MT; Hussain A; Hassan MI
ACS Omega; 2020 Jun; 5(24):14720-14729. PubMed ID: 32596609
[TBL] [Abstract][Full Text] [Related]
16. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis.
Sun M; Deng R; Wang Y; Wu H; Zhang Z; Bu Y; Zhang H
Life Sci; 2020 Sep; 256():117988. PubMed ID: 32569777
[TBL] [Abstract][Full Text] [Related]
17. Morin reduces hepatic inflammation-associated lipid accumulation in high fructose-fed rats via inhibiting sphingosine kinase 1/sphingosine 1-phosphate signaling pathway.
Wang X; Zhang DM; Gu TT; Ding XQ; Fan CY; Zhu Q; Shi YW; Hong Y; Kong LD
Biochem Pharmacol; 2013 Dec; 86(12):1791-804. PubMed ID: 24134913
[TBL] [Abstract][Full Text] [Related]
18. Triple Negative Breast Cancer Depends on Sphingosine Kinase 1 (SphK1)/Sphingosine-1-Phosphate (S1P)/Sphingosine 1-Phosphate Receptor 3 (S1PR3)/Notch Signaling for Metastasis.
Wang S; Liang Y; Chang W; Hu B; Zhang Y
Med Sci Monit; 2018 Apr; 24():1912-1923. PubMed ID: 29605826
[TBL] [Abstract][Full Text] [Related]
19. Role for sphingosine kinase 1 in colon carcinogenesis.
Kawamori T; Kaneshiro T; Okumura M; Maalouf S; Uflacker A; Bielawski J; Hannun YA; Obeid LM
FASEB J; 2009 Feb; 23(2):405-14. PubMed ID: 18824518
[TBL] [Abstract][Full Text] [Related]
20. Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells.
Böhm A; Flößer A; Ermler S; Fender AC; Lüth A; Kleuser B; Schrör K; Rauch BH
Cardiovasc Res; 2013 Aug; 99(3):505-13. PubMed ID: 23658376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
